Market Tracker

02/20 1:05pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.4452
Delayed Data
As of Feb 17
 +0.0053 / +1.20%
Today’s Change
0.26
Today|||52-Week Range
1.51
-30.16%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.44
Today’s open0.43
Day’s range0.43 - 0.45
Volume359,132
Average volume (3 months)774,403
Market cap$69.3M
Dividend yield--
Data as of 4:02pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc-0.05-1.31%
AGLEAeglea Bio Therapeut...+0.12+2.35%
NNVCNanoViricides Inc+0.01+0.89%
PULMPulmatrix Inc-0.19-4.52%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
Chief Operating &
Financial Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts